Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Benjamin Rougeau

Researcher

Unknown Researcher

2 h-index 3 pubs 44 cited

Biography and Research Information

OverviewAI-generated summary

Benjamin Rougeau's research focuses on the design, synthesis, and development of novel chemical compounds with potential therapeutic applications. His recent work includes the creation of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol, a compound investigated as a dual inhibitor of fatty acid biosynthesis (FASII) for the treatment of Methicillin-resistant *Staphylococcus aureus* (MRSA) infections. Rougeau has published three scholarly works with a total of 44 citations and an h-index of 2. He has collaborated on publications with researchers from Arkansas State University, including Mohammad A. Alam, Fabricio Medina-Bolívar, Gaurav Gajurel, and Robert C. Shields.

Metrics

  • h-index: 2
  • Publications: 3
  • Citations: 44

Selected Publications

  • Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection (2026)
    ChemRxiv 1 citation DOI OpenAlex
  • Adsorption of catechol and hydroquinone on titanium oxide and iron (III) oxide (2020)
    Journal of environmental chemical engineering 41 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

11 Collaborators 1 Institution 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics